Toxicological evaluation of long-term intravenous administration of amitraz in horses

With the aim of determining the possible toxicity of amitraz after its prolonged use in horses, six English Thoroughbred horses received intravenous injections of amitraz (0.05, 0.10 or 0.15 mg/kg) weekly for four months, constituting the experimental group. Eight other animals (control group), via the same route following the same drug administration schedule and period of time, received the vehicle, dimethylformamide. At the end of this period, blood was collected from all the animals, and a comparison was made of the means of the values obtained for the various blood analyses: complete hemogram, alkaline phosphatase, gamma-glutamyltransferase, blood urea nitrogen, lactate dehydrogenase, aspartate aminotransferase, creatine phosphokinase, glucose, albumin, total protein, creatinine, Na+ , K+, Cl- and CO2. The results for the biochemical characteristics showed that only the mean value for urea of the animals submitted to treatment with amitraz was significantly different than the mean value obtained for the control group. The analyses of the hematological characteristics showed that no significant differences between groups were observed. Similarly, the measurement of blood electrolyte levels demonstrated that long-term treatment with amitraz did not cause significant changes in the variables analyzed. The results indicate that amitraz, given in the doses employed in this study, did not show signs of inducing toxic effects in vital organs, even after prolonged administration

Toxicological evaluation of long-term intravenous administration of amitraz in horses

Estudou-se a possível toxicidade do uso prolongado do amitraz em eqüinos utilizando-se seis éguas Puro Sangue Inglês, as quais receberam injeções intravenosas de amitraz (0,05, 0,10 ou 0,15 mg/kg) semanalmente, durante quatro meses (grupo experimental). Outros oito animais (grupo-controle), seguindo o mesmo esquema de administração e período, receberam o veículo dimetilformamida. Ao final desse período colheram-se amostras de sangue dos animais e compararam-se as médias dos valores obtidos para as seguintes variáveis do sangue: hemograma completo, fosfatase alcalina, gama-glutamiltransferase, nitrogênio uréico, desidrogenase láctica, aspartato aminotransferase, creatina fosfoquinase, glucose, albumina, proteína total, creatinina, Na+ , K+, Cl- e CO2. Apenas as médias dos valores de nitrogênio uréico dos animais submetidos ao tratamento com amitraz foram diferentes das médias dos valores obtidos para o grupo-controle. As análises das características hematimétricas mostraram que não houve diferenças significativas quando se compararam os dois grupos. As dosagens de eletrólitos no sangue também demonstraram que o tratamento prolongado com amitraz não causou alterações significativas nas características analisadas. O amitraz na dosagem empregada não induziu efeitos tóxicos sobre órgãos vitais, mesmo após administração prolongada.With the aim of determining the possible toxicity of amitraz after its prolonged use in horses, six English Thoroughbred horses received intravenous injections of amitraz (0.05, 0.10 or 0.15 mg/kg) weekly for four months, constituting the experimental group. Eight other animals (control group), via the same route following the same drug administration schedule and period of time, received the vehicle, dimethylformamide. At the end of this period, blood was collected from all the animals, and a comparison was made of the means of the values obtained for the various blood analyses: complete hemogram, alkaline phosphatase, gamma-glutamyltransferase, blood urea nitrogen, lactate dehydrogenase, aspartate aminotransferase, creatine phosphokinase, glucose, albumin, total protein, creatinine, Na+ , K+, Cl- and CO2. The results for the biochemical characteristics showed that only the mean value for urea of the animals submitted to treatment with amitraz was significantly different than the mean value obtained for the control group. The analyses of the hematological characteristics showed that no significant differences between groups were observed. Similarly, the measurement of blood electrolyte levels demonstrated that long-term treatment with amitraz did not cause significant changes in the variables analyzed. The results indicate that amitraz, given in the doses employed in this study, did not show signs of inducing toxic effects in vital organs, even after prolonged administration.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

Comparison between specific and nonspecific tests for evaluating the physical fitness of show jumping horses

Show jumping is a century-old Olympic sport performed worldwide. However, despite the prominence of this sport, there is currently no satisfactory evaluation of the physical fitness of its horses. Our study compared two standardised exercise tests (specific and nonspecific for show jumpers) to determine the importance of a show jumping specific evaluation test. Sixteen horses were divided into two performance groups (high and low performance), and all horses performed standardised exercise tests without jumps (SET1) and with jumps (SET2). Heart rate, blood lactate, glucose, blood gas, haematological parameters, and plasma ions were measured before and after the tests, and performance indices were calculated. Both exercise tests (SET1 and SET2) resulted in changes in nearly all measured variables that were expected, based on other studies, for the duration and nature of the exercise performed. Differences between the two performance groups were observed for lactate and glucose, as well as some blood gas variables and performance indicators. These differences might have been the result of better cardiovascular and metabolic adaptation of the high performance group to the show jumping exercises. For the SET1, differences between groups were mainly noted for variables related to aerobic capacity, which suggests that this measurement is important for the evaluation of equine performance in show jumping. The SET2 was capable of detecting different horse performance levels that could not be detected by the SET1, which indicates that a specific test for show jumping (that includes jumping movements) could provide important information for the evaluation of show jumpers. Based on our findings, we recommend that the SET2 be included in future protocols for evaluating jumping horsesFil: Soares, O.A.B.. Universidade de Sao Paulo; Brasil. Agulhas Negras Military Academy; BrasilFil: Ferraz, G.C.. Universidade de Sao Paulo; BrasilFil: Trigo, Pablo Ignacio. Universidad Nacional de La Plata; ArgentinaFil: D'Angelis, F.H.F.. Universidade de Sao Paulo; BrasilFil: Feringer Júnior, W.H.. Universidade de Sao Paulo; BrasilFil: Nardi, K.B.. Universidade de Sao Paulo; BrasilFil: Almeida, F.Q.. Universidade Federal do Rio de Janeiro; BrasilFil: Queiroz Neto, A.. Universidade de Sao Paulo; Brasi